← Back to MGRX

Mangoceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 19/05/2026Sep 2025Filed 14/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 19/05/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/11/2025Mar 2024Filed 15/05/2025
$0.1$0.1$0.1$0.2$0.1$0.1$0.2$0.2
−$1.3−$3.4−$7.6−$5.4−$4.8−$2−$2.4−$2.4
−$0.09−$0.22−$0.69−$0.57−$1.12−$1.14−$1.37−$1.50
171612104.621.71.6

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.